Microbot Medical Inc [NASDAQ: MBOT] stock went on an upward path that rose over 9.34% on Wednesday, amounting to a one-week price increase of more than 29.22%.
Over the last 12 months, MBOT stock rose by 48.51%. The one-year Microbot Medical Inc stock forecast points to a potential upside of 71.57. The average equity rating for MBOT stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $55.79 million, with 28.03 million shares outstanding and 22.98 million shares in the current float. Compared to the average trading volume of 2.41M shares, MBOT stock reached a trading volume of 9574429 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Microbot Medical Inc [MBOT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBOT shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBOT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Microbot Medical Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 13, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $10 to $12. The new note on the price target was released on December 24, 2019, representing the official price target for Microbot Medical Inc stock. Previously, the target price had yet another raise to $1.75, while Ladenburg Thalmann analysts kept a Buy rating on MBOT stock.
The Average True Range (ATR) for Microbot Medical Inc is set at 0.32 The Price to Book ratio for the last quarter was 8.70, with the Price to Cash per share for the same quarter was set at 0.16.
MBOT Stock Performance Analysis:
Microbot Medical Inc [MBOT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 29.22. With this latest performance, MBOT shares gained by 104.59% in over the last four-week period, additionally plugging by 87.74% over the last 6 months – not to mention a rise of 48.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBOT stock in for the last two-week period is set at 59.53, with the RSI for the last a single of trading hit 59.18, and the three-weeks RSI is set at 59.86 for Microbot Medical Inc [MBOT]. The present Moving Average for the last 50 days of trading for this stock 1.2359, while it was recorded at 1.8040 for the last single week of trading, and 1.0488 for the last 200 days.
Insight into Microbot Medical Inc Fundamentals:
Microbot Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.64 and a Current Ratio set at 3.64.
Microbot Medical Inc [MBOT] Institutonal Ownership Details
There are presently around $7.46%, or 7.57%% of MBOT stock, in the hands of institutional investors. The top three institutional holders of MBOT stocks are: VANGUARD GROUP INC with ownership of 0.46 million shares, which is approximately 3.2694%. BLACKROCK INC., holding 0.14 million shares of the stock with an approximate value of $$0.14 million in MBOT stocks shares; and BLACKROCK INC., currently with $$0.12 million in MBOT stock with ownership which is approximately 0.8533%.
